date/time interval
- January 1, 2026 - December 31, 2028
Targeting DUSP26 to enhance beta cell function and viability for the treatment of type 2 diabetes
Grant
Overview
awarded by
administered by
sponsor award ID
- ADA 253507-01
Affiliation
contributor
- Lima, Renan Principal Investigator 2026 - 2028